T1	Participants 184 419	A total of 269 patients, who presented with symptoms and electrocardiographic signs suggesting acute myocardial infarction were randomized to acute intravenous and subsequent oral therapy with propranolol (n = 134) or placebo (n = 135)
T2	Participants 421 531	Eligibility for acute beta-blocker therapy was determined on the basis of readily available, noninvasive tests
T3	Participants 1538 1637	patients with acute myocardial infarction who are selected on the basis of simple clinical criteria
